Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: mopgcw who wrote (914)	1/31/2002 7:31:48 PM
From: SemiBull	Respond to of 3044

Millennium Pharmaceuticals Announces Webcast of Presentation at the Merrill Lynch Global Drug, Device and Biotech Conference CAMBRIDGE, Mass., Jan. 31 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM - news) announced today that its presentation to the U.S. Bancorp Piper Jaffray Health Care Conference will be webcast live and may be accessed under the ``investor relations'' tab at www.millennium.com. (Photo: newscom.com ) Millennium senior management will provide an overview of the Company. The presentation will be delivered at 2:45pm Eastern Time on February 7, 2002, from The Grand Hyatt Hotel in New York City. Millennium, a leading biopharmaceutical company, applies its comprehensive and integrated science and technology platform for the discovery and development of breakthrough therapeutic and predictive medicine products, with a goal of delivering personalized medicine. Through the industrialization of this gene-to-patient platform, Millennium is also striving to accelerate the process of drug discovery and development. Headquartered in Cambridge, Massachusetts, Millennium currently employs more than 1,500 people. Editor's Note: This release is available on Millennium's website at www.millennium.com Contact: Cynthia Clayton (investor relations) (617) 551-8607 Millennium Pharmaceuticals, Inc. SOURCE: Millennium Pharmaceuticals, Inc.